Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part Randomized Double-Blinded Placebo-Controlled, Phase 1 Study of Single and Multiple Ascending Doses of MH-001 in Healthy Participants

NCT06780254 is registered in ClinicalTrials.gov with Vespina Lifesciences Inc. as lead sponsor.

NCT NCT06780254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part Randomized Double-Blinded Placebo-Controlled, Phase 1 Study of Single and Multiple Ascending Doses of MH-001 in Healthy Participants
Lead sponsor
Vespina Lifesciences Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 9, 2024
Completion date
June 26, 2025
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy